Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Agostinelli

Showing results (171-180 of 195) with videos related to

Pageof 20
Sort By:
International Journal of Molecular Sciences|June 28, 2023
Follicular Lymphoma Microenvironment Traits Associated with Event-Free SurvivalMaria Maddalena Tumedei, Filippo Piccinini, Irene Azzali, et al.
American Journal of Blood Research|March 21, 2012
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experienceClaudia Mannu, Anna Gazzola, Francesco Bacci, et al.
Hematological Oncology|July 21, 2019
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD NetworkIrene Della Starza, Marzia Cavalli, Lucia Anna De Novi, et al.
Haematologica|September 9, 2010
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomasScott J Rodig, Jeffery L Kutok, Jennifer C Paterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Tumor immune microenvironment-associated prognostic and mifamurtide-response gene signatures for localized osteosarcoma: a correlative study of the ISG/OS2 trialEmanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri, et al.
Blood|September 2, 2011
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphomaDavide Rossi, Silvia Deaglio, David Dominguez-Sola, et al.
Histopathology|May 5, 2021
Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regressionMassimo Granai, Stefano Lazzi, Virginia Mancini, et al.
Haematologica|August 21, 2020
A three-gene signature based on <i>MYC</i>, <i>BCL-2</i> and <i>NFKBIA</i> improves risk stratification in diffuse large B-cell lymphomaEnrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Hemasphere|September 13, 2021
Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD NetworkBarbara Mantoan, Elisa Genuardi, Martina Ferrante, et al.
Journal of Hematology & Oncology|November 7, 2015
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemiaIlaria Iacobucci, Andrea Ghelli Luserna Di Rorà, Maria Vittoria Verga Falzacappa, et al.
Pageof 20

Showing results (171-180 of 195) with videos related to

Sort By:
Pageof 20
International Journal of Molecular Sciences|June 28, 2023
Follicular Lymphoma Microenvironment Traits Associated with Event-Free SurvivalMaria Maddalena Tumedei, Filippo Piccinini, Irene Azzali, et al.
American Journal of Blood Research|March 21, 2012
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experienceClaudia Mannu, Anna Gazzola, Francesco Bacci, et al.
Hematological Oncology|July 21, 2019
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD NetworkIrene Della Starza, Marzia Cavalli, Lucia Anna De Novi, et al.
Haematologica|September 9, 2010
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomasScott J Rodig, Jeffery L Kutok, Jennifer C Paterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Tumor immune microenvironment-associated prognostic and mifamurtide-response gene signatures for localized osteosarcoma: a correlative study of the ISG/OS2 trialEmanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri, et al.
Blood|September 2, 2011
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphomaDavide Rossi, Silvia Deaglio, David Dominguez-Sola, et al.
Histopathology|May 5, 2021
Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regressionMassimo Granai, Stefano Lazzi, Virginia Mancini, et al.
Haematologica|August 21, 2020
A three-gene signature based on <i>MYC</i>, <i>BCL-2</i> and <i>NFKBIA</i> improves risk stratification in diffuse large B-cell lymphomaEnrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Hemasphere|September 13, 2021
Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD NetworkBarbara Mantoan, Elisa Genuardi, Martina Ferrante, et al.
Journal of Hematology & Oncology|November 7, 2015
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemiaIlaria Iacobucci, Andrea Ghelli Luserna Di Rorà, Maria Vittoria Verga Falzacappa, et al.
Pageof 20